Radeno News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Radeno. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Radeno Today - Breaking & Trending Today
A study by the Tear Science Lab at Narayana Nethralaya, Bengaluru, has discovered a connection between low vitamin D levels and severe conjunctivitis. The research found that 92% of patients with the illness had low levels of vitamin D, with some having levels as low as 5, compared to the recommended range of around 30. The weak immune response resulting from low vitamin D causes an unusual viral response, leading to severe conjunctivitis. The condition is pervasive across India, with between 57% and 60% of sufferers having allergies, a contributory factor in the illness. ....
Fall last year. we never see it in the surgeon and fall. we see it in the winter. why are we seeing hepatitis cases linked to adeno. monkeypox. do you know who may be saying this the top virology just in the world dr. marianne coopman in netherlands is actually studying this in little kids. do you know what she found? her group found that they don t have the antibodies against regular viruses that they normally would have. so, last year, and the year before when you and i were saying caution, what s the collateral damage of these lockdowns of the masks, of the hand sizers. remember the deep cleaning, brian? the deep cleaning for a virus that never even spread on surfaces? collateral damage. brian: now they still have in new york city toddlers, pre-schoolers who have to wear a mask because there is no vaccine for them. we ll talk about that. how political this whole thing was and now getting more ....
Growing as more states investigate cases of children developing the liver illness without a known cause. and now research finds coronavirus might be linked to cases of severe hepatitis in our children. dr. freda fisher is certified in pediatrics, neff rolling and internal medicine and joins us now. good morning, dr. freed danchts good morning. ainsley: how do we know or do we know is this connected with covid? is it connected with the vaccine? we do not know if it s connected to covid. but there is a theory. we do know that it is not connected to the vaccine because most of the children who are falling ill are less than 10 years of age the majority have not received a covid-19 vaccine. we do not believe there is a connection. there is a difference. ainsley: go ahead. i m sorry. we know there is a connection with the adeno virus. most of the cases have been tested for adeno listed in the gastroenterology especiallyizing in liver disease. the theory is that some of these young ch ....
Uneasy about going back. that s presumably because of all the restrictions that the pandemic is caused them over the last 18 months or so, which they had to learn. can tehran learn those restrictions through treatment, through adeno, some sort of perhaps talking to a counsellor? i some sort of perhaps talking to a counsellor? counsellor? i think it s a really tood counsellor? i think it s a really good question. counsellor? i think it s a really good question. i counsellor? i think it s a really good question. i think- counsellor? i think it s a really good question. i think it s - counsellor? i think it s a really good question. i think it s kind counsellor? i think it s a really i good question. i think it s kind of a spectrum disorder. there are a lot of people who could have a good companion and get out there and kind of a graded fashion. going from less difficult to more ethical things to do. that s what first has to happen. i think we have to raise awareness, have people rea ....
(2) Joining forces to develop gene therapies for multiple life-threatening disorders SIRION Biotech GmbH, a world leader in viral vector-based gene delivery technologies for gene cell therapy, announced today that it signed a license and collaboration agreement with Sanofi, a global biopharmaceutical company, to develop improved tissue-selective adeno-associated virus (AAV) vectors to realize effective gene therapy treatments for disorders affecting major human organs. AAV vectors are a promising and clinically validated gene delivery platform for the potential treatment of a variety of human diseases. Sanofi, together with SIRION Biotech and Prof. Dirk Grimm, a world-renowned and pioneering scientist in the field of AAV biology and application working at Heidelberg University Hospital (Germany), will combine their proprietary technology platforms to create a next generation of AAV vectors. The goal of this collaboration is to develop new and modified AAV capsids ....